Lubin et al., 2008) are also situated in regions with low or moderate CG frequency, respectively
Proposed pathways include modulation of multiple neurotransmitter systems (influencing serotonin, dopamine, norepinephrine, GABA, glutamate levels), possible involvement of NMDA receptors, alpha-1 adrenergic signaling (e.g., potentiating pineal acetyltransferase activity), inhibition of somatostatin release via dopaminergic routes, reduced ACTH/cortisol for stress buffering, and stimulated growth hormone or somatoliberin secretion
But research on amylin receptors is suggesting that a different neuropeptide pathway might be the next big thing
Retatrutide: Onderzoek eerst de unieke eigenschappen van deze innovatieve triple agonist (GLP-1, GIP en glucagonreceptor) binnen metabole in-vitro studies